Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
Tsushima H, Morimoto S, Fujishiro M, Yoshida Y, Hayakawa K, Hirai T, Miyashita T, Ikeda K, Yamaji K, Takamori K, Takasaki Y, Sekigawa I, Tamura N.
Tsushima H, et al. Among authors: sekigawa i.
Autoimmunity. 2017 Aug;50(5):329-335. doi: 10.1080/08916934.2017.1344970. Epub 2017 Jul 6.
Autoimmunity. 2017.
PMID: 28682648